News | Enterprise Imaging | February 06, 2019

Philips Spotlights IntelliSpace Enterprise Edition at HIMSS 2019

Next-generation enterprise-wide health informatics platform now includes IntelliSpace Precision Medicine Oncology, IntelliSpace Genomics and interoperable clinical data sharing with IntelliSpace Exchange

Philips Spotlights IntelliSpace Enterprise Edition at HIMSS 2019

February 6, 2019 — Philips announced it has expanded its IntelliSpace Enterprise Edition, which combines Philips Radiology, Cardiology portfolios and PerformanceBridge, to now include the new IntelliSpace Precision Medicine Oncology, IntelliSpace Precision Medicine Genomics and IntelliSpace Exchange solutions.

Being showcased at the Healthcare Information Management Systems Society (HIMSS) 2019 annual event, Feb. 11-15 in Orlando, Fla., the enhanced integration builds on the existing suite of offerings from IntelliSpace Enterprise Edition to provide an enterprise-wide health informatics solution. With this latest expansion, health systems now have access to advanced technology solutions to help reduce costs, improve patient and staff satisfaction, and transform towards value-based care.

Precision medicine has great potential for individualized diagnoses and treatment for cancer patients. However, due to the increasing number of complex data sources needed to leverage it effectively, clinicians need tools to help them seamlessly aggregate all key data to provide a clear, intuitive view of a patient’s condition. With the latest additions to the solution, IntelliSpace Enterprise Edition is designed to enable the seamless flow of data, information enterprise management and improved care, combining radiology, cardiology and growing towards precision medicine.

CarolinaEast, an award-winning health system for patient experience and cardiac care based in New Bern, N.C., was one of the first to collaborate with Philips to implement IntelliSpace Enterprise Edition, which began with the Philips Radiology and Cardiology portfolios. Having first implemented the solution in the fall of 2018, early results show improvements in workflow, communication and operational efficiencies.

“CarolinaEast has been working with Philips for many years, and the company has always proven to be a valuable partner. With the introduction of IntelliSpace Enterprise Edition, Philips has further demonstrated its commitment to our success by providing insight into best practices and the tools to help us achieve our critical goals,” said Mike Ciancio, imaging systems administrator, CarolinaEast Health System. “Philips has helped us identify areas for improvement so we can streamline and standardize our processes to help deliver more efficient and seamlessly integrated care.”

Philips IntelliSpace Enterprise Edition brings the managed services business model to more clinical solutions, for enterprise-wide informatics across care settings. New features include:

  • IntelliSpace Precision Medicine Oncology – features workflow solutions from analysis to treatment decision to enable healthcare organizations to effectively launch, implement and scale precision medicine programs.
  • IntelliSpace Precision Medicine Genomics – seamless workflow platform brings together genomic data alongside disease histology and patient phenotype for a comprehensive biomarker-informed diagnostic and therapeutic picture.
  • IntelliSpace Exchange – provides hospital networks the possibility to easily and seamlessly exchange clinical information, to help improve the overall experience and efficiency through standards-based interoperability.

The IntelliSpace Enterprise Edition informatics suite leverages adaptive intelligence and advanced technology, powered by Philips HealthSuite, to enable health systems to make informed and timely decisions, in the right place at the right time. Beginning in 2019, IntelliSpace Enterprise Edition will continue to expand with additional solutions across new clinical domains, and will become available to more markets internationally.

For more information: www.usa.philips.com/healthcare

Related Content

The U.S. Food and Drug Administration (#FDA) authorized marketing of #Medtronic's #GIGenius, the first device that uses #artificialintelligence (#AI) based on #machinelearning to assist #clinicians in detecting #lesions (such as #polyps or suspected tumors) in the #colon in real time during a c#olonoscopy.

The GI Genius intelligent endoscopy module works in real-time, automatically identifying and marking (with a green box) abnormalities consistent with colorectal polyps, including small flat polyps.

News | Artificial Intelligence | April 12, 2021
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...
Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented

Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented as the areas with Hounsfield units below this threshold for the IMAT (arrowheads). Image courtesy of the Radiological Society of North America

News | Computed Tomography (CT) | April 07, 2021
April 7, 2021 — Body composition information derived from routine chest...
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Nano-X Imaging Ltd (Nanox), an innovative medical imaging technology company, announced that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration.
News | X-Ray | April 02, 2021
April 2, 2021 — Nano-X Imaging Ltd.
Elsevier’s STATdx, a leading radiology diagnostic decision support solution, now includes select Merit-Based Incentive Payment System (MIPS) Measures validated by MDinteractive
News | Clinical Decision Support | April 02, 2021
April 2, 2021 — Elsevier, a global leader in research publishing and information analytics, announced a partnership w